D-0594-2016 Class II Terminated

Recalled by Pharmakon Pharmaceuticals — Noblesville, IN

FDA drug recall D-0594-2016 was initiated by Pharmakon Pharmaceuticals on Aug 19, 2015 and is designated Class II. Reason for recall: Stability data does not support expiry. The recall status is terminated (terminated May 9, 2017). Affected quantity: 4100.

Recall Details

Product Type
Drugs
Report Date
Feb 3, 2016
Initiation Date
Aug 19, 2015
Termination Date
May 9, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4100

Product Description

Ondansetron 2 mg/mL, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.

Reason for Recall

Stability data does not support expiry.

Distribution Pattern

Nationwide

Code Information

All lots with expiration dates up to 11/17/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0594-2016
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.